The global Pharmaceutical Glass Packaging Market size is
expected to reach USD 22.05 billion by 2025, according to a new report by Grand
View Research, Inc., registering a CAGR of 6.3% during the forecast period.
Spiraling sale of generic drugs in developed as well as developing economies is
projected to drive the demand for pharmaceutical glass packaging. Glass has a
well-defined supply chain in the pharmaceutical industry and is traditionally
used for parenteral drug packaging. Extensive R&D is being conducted by
product manufacturers in order to minimize negative aspects of glass, such as
high susceptibility to breaking and delamination, as well as to improve the
quality & efficacy of the product.
The pharmerging market is
anticipated to witness phenomenal growth owing to favorable government policies
and increased healthcare awareness. Governments of developing nations are
expanding their public or private healthcare coverage and simultaneously making
efforts to minimize out-of-pocket medical expenses for the consumers.
Increasing government efforts to reduce healthcare cost and promotion of
low-cost generic drugs are estimated to fuel the utilization of glass packaging
over the coming years.
Emergence of novel drugs such
as cancer drugs and bio-therapeutics is likely to help the market gain traction
over the coming years. In an effort to safeguard patient health, guidelines for
packaging of biological drugs have been made highly stringent, which
necessitates constant development in the field of pharmaceutical packaging.
Aforementioned factors promote manufacturers to adopt advanced techniques,
thereby driving the market.
In primary pharmaceutical packaging,
glass has an advantage over plastic as plastic production requires raw
materials such as polyethylene, polypropylene, and polystyrene, which are
largely dependent on fluctuating petroleum industry. Manufacturers use soda
lime, quartz, and other additives for manufacturing glass. These raw materials
are easily available in the market by numerous suppliers. Recent developments
in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an
Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017.
This technology has the ability to minimize particle loads and meet strict
requirements for therapeutic protein products for better deliver of drug.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-glass-packaging-market
Further Key Findings from the Report Suggest:
- The vials segment is projected to ascend at a
CAGR of 6.9% in terms of revenue over the forecast period
- The bottles segment dominated the global
pharmaceutical glass packaging market in 2016 in terms of revenue and is
anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high
penetration of plastics in the manufacturing of bottles
- The generic drug segment accounted for 69.8% of
the market in 2016 due to rapidly increasing manufacturing volumes of
generic drugs in emerging economies
- Europe is expected to witness considerable
growth during the forecast period owing to constant development in the
medical field aimed at improving health and quality of life
- Some of the key companies present in the market
are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT
AG; Şişecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato
Group; and Owens-Illinois, Inc.
Grand View Research has
segmented the global pharmaceutical glass packaging market on the basis of
product, drug type, and region:
Pharmaceutical Glass Packaging Product Outlook (Revenue,
USD Million, 2014 - 2025)
- Vials
- Small vials (<30ml)
- Large vials (>30ml)
- Bottles
- Small Bottles (< 1000 ml)
- Large Bottles (> 1000 ml)
- Cartridges & Syringes
- Ampoules
Pharmaceutical Glass Packaging Drug Type Outlook
(Revenue, USD Million, 2014 - 2025)
- Generic
- Branded
- Biologic
Pharmaceutical Glass Packaging Regional Outlook (Revenue,
USD Million, 2014 - 2025)
- North America
- U.S.
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- South Korea
- Central & South America
- Brazil
- Middle East & Africa
No comments:
Post a Comment